What can HealthTech founders do to significantly increase the chances of their merger or acquisition closing in today's market?
- Lloyd Price
- Jun 20
- 4 min read
The HealthTech M&A market is dynamic, with increased activity in distressed assets and a focus on strategic acquisitions, especially in AI-driven care and data analytics. Valuations are moderating but still vary significantly by sub-sector and company profile.
To significantly increase the chances of a successful merger or acquisition, Nelson Advisors recommend HealthTech founders focus on the following key areas:
1. Proactive Preparation & Data Excellence
Invest in Data Infrastructure Early: Organizations with established data capabilities before pursuing deals achieve significantly better M&A outcomes. This means having robust data governance, quality, security, and regulatory compliance (e.g., HIPAA, GDPR) embedded from the outset.
Comprehensive Data Analytics: Go beyond traditional financial metrics. Systematically gather and analyse data on clinical outcomes, operational efficiency, cultural compatibility, and technological maturity. Predictive modelling of future revenue, regulatory risks, and market conditions can reduce valuation uncertainty.
Cross-Domain Analytics: The most valuable insights emerge from connecting financial, clinical, operational, and technological data, rather than analysing domains in isolation.
Detailed Documentation & Cleanliness: Ensure all aspects of your company – legal, commercial, financial, HR, and technical – are meticulously documented and readily available. This includes organizational charts, contracts, financial statements, IP agreements, and compliance records. Any "skeletons in the closet" will likely be uncovered during due diligence and can derail a deal.
2. Strong Financial & Commercial Foundations
Demonstrate Clear Value: Clearly articulate your value proposition, market fit, and how your technology addresses significant healthcare challenges. Highlight strong financial performance (revenue, growth, profitability), a large and engaged user base, and clear market traction.
Sustainable Business Model: Show consistent revenue growth and strong gross margins. Buyers are increasingly cautious and focused on profitability. Companies with lower customer acquisition costs (CACs) are also highly valued.
Strategic Alignment: Understand what strategic buyers are looking for (e.g., technology that plugs portfolio gaps like AI diagnostics or patient management tools). Position your company as a clear strategic fit for potential acquirers.
Realistic Valuation Expectations: Be prepared for potentially lower multiples, especially if your company is distressed. While AI-driven diagnostics might still command premium appeal, overall sector valuations are moderating. Understand the specific valuation multiples for your HealthTech sub-sector.
3. Robust Technology & Intellectual Property
Thorough Technology Due Diligence (TDD) Readiness: Technology is a critical asset. Be ready for a deep dive into your software, IT infrastructure, cybersecurity, data privacy practices, and intellectual property. Address any potential issues like technical debt, security vulnerabilities, or IP disputes proactively.
Scalability and Interoperability: Buyers will assess your technology's ability to scale and integrate with their existing systems. Healthcare technology involves complex systems and diverse data formats (e.g., EHRs), so demonstrating interoperability is crucial.
Strong IP Portfolio: Companies with valuable intellectual property (patents, trademarks, proprietary code) are typically valued at a higher multiple. Ensure clear ownership and protection of your IP.
AI and SaMD Specifics: If your company is in Software as a Medical Device (SaMD) or AI as a Medical Device (AIaMD), emphasise strong in-house clinical expertise, the quality and alignment of your evidence (studies on final products, not prototypes), and a clear understanding of the clinical context for your product. Be ready to demonstrate adequate budgets and timelines for product development, QMS, V&V testing, and regulatory submissions.
4. Operational Excellence & Talent Management
Operational Efficiency: Show strong operational metrics like staff retention rates, technology integration milestones, and process efficiency improvements.
Talent Retention: Acquirers often value the talent within a company. Foster a strong company culture, invest in your employees, and minimise key person risk by developing a strong leadership team.
Clear Roles and Responsibilities: A well-structured organisation with clear roles and responsibilities makes integration smoother.
Cultural Compatibility: Proactively address potential cultural integration. Misaligned cultures are a significant reason M&A deals fail.
5. Regulatory Compliance & Risk Mitigation
Rigorous Compliance: Healthcare is highly regulated. Ensure your company adheres to all relevant healthcare regulations (HIPAA, GDPR, etc.) from the outset. Be prepared for increased regulatory scrutiny in areas like data privacy and antitrust.
Compliance Integration Planning: Anticipate and plan for the complexities of integrating compliance frameworks. Discovering significant compliance gaps during due diligence can deter acquirers.
Risk Management: Identify and mitigate potential risks early. This includes financial liabilities, unsustainable business models, cybersecurity vulnerabilities, and regulatory non-compliance.
6. Strategic Planning for Integration
Start Integration Planning Early: Comprehensive integration planning should begin during due diligence, not after closing the deal. This includes technology, personnel, and processes.
Leadership & Governance: Appoint integration leaders and set a clear governance framework with defined decision-making processes.
Communication: Maintain open and transparent communication with all stakeholders throughout the process.
In today's cautious market, buyers are focusing heavily on value and profitability, and are less willing to overpay. Therefore, HealthTech founders who can clearly demonstrate strong fundamentals, mitigate risks, and show a clear path to successful integration will significantly enhance their chances of a successful M&A closing.
Nelson Advisors > Healthcare Technology M&A
Nelson Advisors specialise in mergers, acquisitions & partnerships for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk
Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
We share our views on the latest Healthcare Technology mergers, acquisitions & partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
Founders for Founders > We pride ourselves on our DNA as ‘HealthTech entrepreneurs advising HealthTech entrepreneurs.’ Nelson Advisors partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #BuySide #SellSide
Nelson Advisors LLP
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Contact Us
Meet Us
Digital Health Rewired > 18-19th March 2025 > Birmingham, UK
NHS ConfedExpo > 11-12th June 2025 > Manchester, UK
HLTH Europe > 16-19th June 2025, Amsterdam, Netherlands
HIMSS AI in Healthcare > 10-11th July 2025, New York, USA
World Health Summit 2025 > October 12-14th 2025, Berlin, Germany
HLTH USA 2025 > October 18th-22nd 2025, Las Vegas, USA
MEDICA 2025 > November 11-14th 2025, Düsseldorf, Germany
Comments